A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy. (Q46571663)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 November 2015
edit
Language Label Description Also known as
English
A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.
scientific article published on 6 November 2015

    Statements

    A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit